dihydroxyphenylalanine has been researched along with Huntington Disease in 52 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Huntington Disease: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)
Excerpt | Relevance | Reference |
---|---|---|
"A 48-year-old man with typical Huntington's disease was investigated with computed tomography (CT) and positron emission tomography." | 1.27 | Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography. ( Frackowiak, RS; Leenders, KL; Marsden, CD; Quinn, N, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 49 (94.23) | 18.7374 |
1990's | 2 (3.85) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (1.92) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Michler, E | 1 |
Hoberück, S | 1 |
Martino, F | 1 |
Platzek, I | 1 |
Kotzerke, J | 1 |
SOURKES, TL | 1 |
PIVNICKI, D | 1 |
BROWN, WT | 1 |
WISEMAN-DISTLER, H | 1 |
MURPHY, GF | 1 |
SANKOFF, I | 1 |
SAINTCYR, S | 1 |
Wöller, W | 1 |
Tegeler, J | 1 |
Magalov, ShI | 1 |
Dadali, EL | 1 |
Hume, SP | 1 |
Lammertsma, AA | 1 |
Myers, R | 1 |
Rajeswaran, S | 1 |
Bloomfield, PM | 1 |
Ashworth, S | 1 |
Fricker, RA | 1 |
Torres, EM | 1 |
Watson, I | 1 |
Jones, T | 1 |
Olney, JW | 1 |
Zorumski, CF | 1 |
Stewart, GR | 1 |
Price, MT | 1 |
Wang, GJ | 1 |
Labruyere, J | 1 |
Martin, WR | 2 |
Hayden, MR | 1 |
Leenders, KL | 1 |
Frackowiak, RS | 1 |
Quinn, N | 1 |
Marsden, CD | 1 |
Klawans, HC | 1 |
Paulson, GW | 5 |
Barbeau, A | 4 |
Yuill, GM | 1 |
Tan, BK | 1 |
Leijnse-Ybema, HJ | 2 |
v d Brand, HJ | 1 |
Klawans, HL | 4 |
Goodman, RM | 1 |
Venters, GA | 1 |
Baskin, F | 1 |
Rosenberg, RN | 1 |
Simanyi, M | 1 |
Gerstenbrand, F | 1 |
Gründig, E | 1 |
Schedl, R | 1 |
Weiss, H | 1 |
Shokeir, MH | 1 |
Bruyn, GW | 1 |
von Wolferen, WJ | 1 |
Walker, JE | 1 |
Hoehn, M | 1 |
Sears, E | 1 |
Lewis, J | 1 |
Schenk, G | 1 |
Bird, ED | 1 |
Iversen, LL | 1 |
Cotzias, GC | 1 |
Papavasiliou, PS | 1 |
Gellene, R | 1 |
Bernheimer, H | 2 |
Birkmayer, W | 3 |
Hornykiewicz, O | 2 |
Curzon, G | 1 |
Cederbaum, S | 1 |
Bird, MT | 2 |
Hartmann-von Monakow, K | 1 |
Bond, PA | 1 |
Ringel, SP | 1 |
Fahn, S | 1 |
Goetz, C | 1 |
Westheimer, R | 1 |
Chase, TN | 3 |
Gordon, EK | 1 |
Ng, LK | 2 |
Candelise, L | 1 |
Faglioni, P | 1 |
Spinnler, H | 1 |
Vignolo, LA | 1 |
Constantinidis, J | 1 |
Rondot, P | 1 |
Dumas, RJ | 1 |
Jellinger, K | 1 |
Seitelberger, F | 1 |
Korczyn, AD | 1 |
Podolsky, S | 2 |
Leopold, NA | 2 |
Low, PA | 2 |
Allsop, JL | 2 |
Halmagyi, GM | 1 |
Re', O | 1 |
Matthews, WB | 1 |
Tarsy, D | 1 |
Leopold, N | 1 |
Sax, DS | 1 |
Cramer, H | 1 |
Saïd, G | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Adenosine A2A Blockade With KW-6002 in Parkinson's Disease[NCT00006337] | Phase 2 | 16 participants | Interventional | 2000-10-31 | Completed | ||
Effect of Antiglutamatergic Treatment in Parkinson's Disease[NCT00013624] | Phase 2 | 20 participants | Interventional | 2001-03-31 | Completed | ||
Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease[NCT00006077] | Phase 2 | 50 participants | Interventional | 2000-08-31 | Completed | ||
Effect of Serotoninergic Treatment in Parkinson's Disease[NCT00009048] | Phase 2 | 30 participants | Interventional | 2001-01-31 | Completed | ||
Levetiracetam Treatment of L-dopa Induced Dyskinesias[NCT00076674] | Phase 2 | 40 participants | Interventional | 2004-01-31 | Completed | ||
AMPA Receptor Blockade With LY300164 in the Treatment of Parkinson's Disease[NCT00004576] | Phase 2 | 20 participants | Interventional | 2000-02-29 | Completed | ||
Prognostic Value of FP-CIT-SPECT in Patients With Parkinson´s Disease[NCT01038310] | 25 participants (Actual) | Observational | 2010-01-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
8 reviews available for dihydroxyphenylalanine and Huntington Disease
Article | Year |
---|---|
Cerebral glucose and dopa metabolism in movement disorders.
Topics: Animals; Brain; Deoxy Sugars; Deoxyglucose; Dihydroxyphenylalanine; Humans; Huntington Disease; Park | 1987 |
Positron emission tomography in movement disorders.
Topics: Brain; Cerebrovascular Circulation; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dystonia; Glu | 1985 |
The biochemistry of dyskinesias.
Topics: Acetylcholine; Animals; Catecholamines; Cats; Copper; Dihydroxyphenylalanine; Dogs; Hepatolenticular | 1967 |
Pathophysiology of schizophrenia and the striatum.
Topics: Adult; Amphetamine; Animals; Basal Ganglia; Catalepsy; Caudate Nucleus; Dihydroxyphenylalanine; Dopa | 1972 |
The pharmacology of extrapyramidal movement disorders.
Topics: Basal Ganglia Diseases; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; Hep | 1973 |
Pathophysiology of drug-induced dyskinesias.
Topics: Brain; Brain Chemistry; Butyrophenones; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; Do | 1972 |
2-Dimethylaminoethanol (deanol): a brief review of its clinical efficacy and postulated mechanism of action.
Topics: Acetylcholine; Blood-Brain Barrier; Brain Chemistry; Carbon Radioisotopes; Child; Choline; Deanol; D | 1974 |
Advances in neurology.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anticoagulants; Anticonvulsants; Antihypertens | 1972 |
3 trials available for dihydroxyphenylalanine and Huntington Disease
Article | Year |
---|---|
Modification of Parkinsonism--chronic treatment with L-dopa.
Topics: Adult; Aged; Agranulocytosis; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Urea Nitrogen; Blo | 1969 |
[10 years of L-DOPA therapy of Parkinson's syndrome].
Topics: Administration, Oral; Amphetamine; Animals; Brain Chemistry; Catecholamines; Clinical Trials as Topi | 1971 |
Letter: Treatment of Huntington's chorea.
Topics: Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Clinical Trials as Topic; Dia | 1973 |
41 other studies available for dihydroxyphenylalanine and Huntington Disease
Article | Year |
---|---|
Diagnosis of Huntington's disease via sequential 18F-DOPA and 18F-FDG PET/MRI.
Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Magnetic Resonan | 2019 |
A CLINICAL AND METABOLIC STUDY OF DOPA (3, 4-DIHYDROXYPHENYLALANINE) AND METHYLDOPA IN HUNTINGTON'S CHOREA.
Topics: Body Fluids; Chorea; Dihydroxyphenylalanine; Drug Therapy; Electroencephalography; Fluids and Secret | 1965 |
[Tardive dyskinesia: clinical picture, prevalence, and pathophysiology].
Topics: Age Factors; Antipsychotic Agents; Diagnosis, Differential; Dihydroxyphenylalanine; Dyskinesia, Drug | 1983 |
[Catecholamine metabolism in Huntington's chorea (in patients and their phenotypically healthy relatives)].
Topics: Adolescent; Adult; Aged; Catecholamines; Child; Dihydroxyphenylalanine; Dopamine; Epinephrine; Femal | 1980 |
The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease.
Topics: Animals; Carbidopa; Carbon Isotopes; Carrier Proteins; Cerebellum; Dihydroxyphenylalanine; Disease M | 1996 |
Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Chick Embryo; Dibenzocyc | 1990 |
Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography.
Topics: Carbon Radioisotopes; Cerebral Cortex; Cerebrovascular Circulation; Corpus Striatum; Dihydroxyphenyl | 1986 |
Predictive test for Huntington's chorea.
Topics: Dihydroxyphenylalanine; Humans; Huntington Disease; Movement Disorders; Neurologic Examination; Neur | 1970 |
Parkinsonism and Huntington's chorea.
Topics: Dihydroxyphenylalanine; Humans; Huntington Disease; Parkinson Disease | 1971 |
Levodopa in Huntington's chorea.
Topics: Chlorpromazine; Dihydroxyphenylalanine; Female; Humans; Huntington Disease; Mental Disorders; Middle | 1972 |
Levodopa in the presymptomatic diagnosis of Huntington's chorea.
Topics: Chemoreceptor Cells; Dihydroxyphenylalanine; Dopamine; Humans; Huntington Disease | 1972 |
Dopa and Huntington's disease.
Topics: Dihydroxyphenylalanine; Humans; Huntington Disease | 1973 |
Dopa as an antimetabolite in Huntington's disease.
Topics: Acylation; Adult; Amino Acyl-tRNA Synthetases; Antimetabolites; Basal Ganglia; Caudate Nucleus; Dihy | 1973 |
[Effect of administration of amino acids, especially of L-DOPA and -methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. 3. Alterations of cerebrospinal fluid in patients with Huntington's chorea after -methyldopa or L-DOPA
Topics: Adult; Aged; Alanine Transaminase; Asparagine; Aspartic Acid; Child; Dihydroxyphenylalanine; Female; | 1973 |
DOPA as anti-metabolite in Huntington's disease.
Topics: Brain; Catechol Oxidase; Dihydroxyphenylalanine; Dopamine; Humans; Huntington Disease; Hydroxydopami | 1973 |
Pathogenesis of Huntington's chorea.
Topics: Dihydroxyphenylalanine; Humans; Huntington Disease | 1973 |
Dimethyl aminoethanol in Huntington's chorea.
Topics: Dihydroxyphenylalanine; Ethanol; Humans; Huntington Disease; Physostigmine | 1973 |
Letter: Huntington's chorea and levodopa.
Topics: Carboxy-Lyases; Dihydroxyphenylalanine; Drug Interactions; Drug Therapy, Combination; Haloperidol; H | 1974 |
Letter: Rigidity in Huntington's chorea.
Topics: Basal Ganglia; Brain; Dihydroxyphenylalanine; Dopamine; Humans; Huntington Disease; Muscle Rigidity; | 1974 |
L-dopa and juvenile Huntington's disease.
Topics: Adolescent; Adult; Dihydroxyphenylalanine; Female; Humans; Huntington Disease; Male | 1969 |
[Homovanillic acid in the cerebrospinal fluid: studies in Parkinson's syndrome and other diseases of the CNS].
Topics: Adult; Aged; Central Nervous System Diseases; Cerebrospinal Fluid; Dihydroxyphenylalanine; Epilepsy; | 1966 |
Tests for Huntington's chorea.
Topics: 5-Hydroxytryptophan; Dihydroxyphenylalanine; Humans; Huntington Disease | 1971 |
Early onset rigid Huntington's disease.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Diagnosis, Differential; Dihydroxyphenylalanine; E | 1970 |
[Specific therapy of extrapyramidal-motor syndromes].
Topics: Analgesics; Athetosis; Chorea; Datura stramonium; Dihydroxyphenylalanine; Dystonia Musculorum Deform | 1969 |
The determination of 4-hydroxy-3-methoxyphenylethylene glycol in urine and CSF using gas chromatography.
Topics: Acetates; Adult; Catechols; Chromatography, Gas; Chromatography, Ion Exchange; Dihydroxyphenylalanin | 1972 |
Use of L-dopa in the detection of presymptomatic Huntington's chorea.
Topics: Adolescent; Adult; Aromatic Amino Acid Decarboxylase Inhibitors; Dihydroxyphenylalanine; False Posit | 1972 |
L-dopa effect in Huntington's chorea.
Topics: Dihydroxyphenylalanine; Humans; Huntington Disease; Parkinson Disease | 1972 |
Presymptomatic detection of Huntington's chorea.
Topics: Adolescent; Adult; Dihydroxyphenylalanine; Eugenics; Humans; Huntington Disease | 1972 |
Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Carbon Radioisotopes; Cerebrospinal Fluid; Child; | 1973 |
[Monoamines and choreic syndromes].
Topics: Amines; Butyrophenones; Chorea; Diazepam; Dihydroxyphenylalanine; Dopamine; Ganglia; Globus Pallidus | 1972 |
[Dopamine and abnormal movements].
Topics: Benserazide; Body Weight; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Therapy, Combination; Electro | 1972 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Biogenic amines in the hypothalamus: effect of L-DOPA on human growth hormone levels in patients with Huntington's chorea.
Topics: Dihydroxyphenylalanine; Growth Hormone; Humans; Huntington Disease; Male; Time Factors | 1973 |
Huntington's chorea: the rigid form (Westphal variant) treated with levodopa.
Topics: Adult; Dihydroxyphenylalanine; Female; Hallucinations; Humans; Huntington Disease | 1974 |
Huntington's chorea--the rigid form (Westphal variant) treated with l-DOPA: a case report.
Topics: Adult; Dihydroxyphenylalanine; Female; Humans; Huntington Disease | 1973 |
Growth hormone abnormalities in Huntington's chorea: effect of L-dopa administration.
Topics: Adult; Aged; Depression, Chemical; Dihydroxyphenylalanine; Glucose Tolerance Test; Growth Hormone; H | 1974 |
The rigid form of Huntington's chorea.
Topics: Adult; Age Factors; Amantadine; Dihydroxyphenylalanine; Female; Humans; Huntington Disease; Movement | 1971 |
Physostigmine in choreiform movement disorders.
Topics: Acetylcholine; Adult; Aged; Art; Athetosis; Chorea; Corpus Striatum; Dihydroxyphenylalanine; Female; | 1974 |
Adenosine 3',5'-monophosphate in cerebrospinal fluid. Effect of drugs and neurologic disease.
Topics: Adolescent; Adult; Aged; Cerebellar Diseases; Child; Cyclic AMP; Dihydroxyphenylalanine; Female; Hom | 1973 |
Serotonergic-dopaminergic interactions and extrapyramidal function.
Topics: Biogenic Amines; Brain; Dihydroxyphenylalanine; Dopamine; Extrapyramidal Tracts; Humans; Huntington | 1974 |
[Dystonias].
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Dihydroxyphenylalanine; Dystonia Musculorum Deformans; Extra | 1972 |